- Delayed again: Canada delays pricing reform until January 2022
- The Access Consortium’s new strategic plan
- The WHO highlights risks of AI in healthcare
- Senate Finance Chair share recommendations for US drug pricing
MFN Policy Is Moving — Join the Conversation (Part II)
US Most Favoured Nation (MFN) policy continues to evolve.
Join our complimentary 30-minute Office Hours session to explore the latest developments and what they could mean for pricing, launch sequencing and global strategy.
Hosted by Paul Craddy & Nicole Lodowski
